New pain block could keep hip surgery patients comfortable for days

NCT ID NCT07643792

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests whether a single injection of a slow-release painkiller (liposomal bupivacaine) into a nerve block can control pain for up to 72 hours after hip fracture surgery in older adults. The standard drug only lasts about 12 hours, often leading to more pain and opioid use. The trial will compare pain scores and opioid consumption in 148 patients aged 55 and older.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine
What this could lead to
If it works, this could provide better pain control for up to 72 hours after hip surgery, reducing the need for opioids and lowering complication risks in older patients.
What could go wrong
This is a small, early-phase trial (148 participants) comparing two types of nerve blocks, so results may not apply broadly. The long-acting drug may not prove significantly better than the standard short-acting one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FASCIA ILIACA BLOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hip fracture Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.